Connection

Charles Bennett to Pharmacovigilance

Back to Details
This is a "connection" page, showing publications Charles Bennett has written about Pharmacovigilance.
Charles Bennett
Connection Strength
1.830
Pharmacovigilance
  1. Investigating Severe Adverse Reactions: Examples of the ANTICIPATE Methodology at Work. Cancer Treat Res. 2022; 184:129-140.
    View in: PubMed
    Score: 0.770
  2. Evaluation of gemtuzumab ozogamycin associated sinusoidal obstructive syndrome: Findings from an academic pharmacovigilance program review and a pharmaceutical sponsored registry. Leuk Res. 2016 May; 44:61-4.
    View in: PubMed
    Score: 0.516
  3. Pharmacovigilance and PML in the oncology setting. Cleve Clin J Med. 2011 Nov; 78 Suppl 2:S13-7.
    View in: PubMed
    Score: 0.381
  4. Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions. PLoS One. 2019; 14(7):e0219521.
    View in: PubMed
    Score: 0.163
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.